151,99 €
The process of labor and delivery has been one of the most perilous activities in human life. The awkward evolutionary compromises giving rise to humans makes birthing potentially life threatening for both mother and child. Despite the development of modern care, labor and delivery continues to be a dangerous process even though the levels of fatality have decreased over the past several decades.
This clinically focused guide to modern labor and delivery care covers low and high-risk situations, the approach of the team in achieving a successful outcome and what to consider when quick decisions have to be made. Aimed at both trainee and practicing obstetrician-gynecologists, this new edition includes practical guidance such as algorithms, protocols, and quick-reference summaries. It is squarely focused on the process of birth and concentrates on modern clinical concerns, blending science with clinical applications.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 1205
Veröffentlichungsjahr: 2016
Cover
Title Page
Contributor List
CHAPTER 1: Antenatal preparation for labor
1.1 Introduction
1.2 Goals of antenatal childbirth education
1.3 Theoretical approaches to antenatal childbirth education
1.4 Effectiveness of childbirth preparation: educational goals and pregnancy outcomes
1.5 Future direction for advancing antenatal childbirth education
1.6 Who teaches childbirth education classes and where?
1.7 Prenatal education class content
1.8 Group prenatal care
1.9 Self-prepared birth plans
References
CHAPTER 2: Normal labor and delivery
2.1 Introduction
2.2 Labor onset
2.3 First stage of labor
2.4 Second stage of labor
2.5 Third stage of labor
2.6 Intrapartum care during normal labor and delivery
2.7 Conclusion
References
CHAPTER 3: Management of labor and delivery in low-risk subjects
3.1 Introduction
3.2 First stage
3.3 Amniotomy
3.4 Second stage
3.5 Perineal massage
3.6 Episiotomy
3.7 Cord clamping
3.8 Third stage
3.9 Conclusion
References
CHAPTER 4: Induction and augmentation of labor
4.1 Introduction
4.2 Indications and contraindications for induction or augmentation of labor
4.3 Risks associated with labor induction
4.4 Predicting success of labor
4.5 Mechanical cervical ripening
4.6 Biochemical agents for cervical ripening
4.7 Oxytocin
4.8 Active management of labor
4.9 Failed induction
4.10 Safety and quality protocols
4.11 Conclusion
References
CHAPTER 5: Fetal monitoring and assessment
5.1 Introduction
5.2 Historical perspectives
5.3 Intrapartum electronic fetal monitoring
5.4 Fetal scalp sampling
5.5 Fetal pulse oximetry
5.6 Fetal ST segment analysis
5.7 Research and the future
References
CHAPTER 6: Operative vaginal delivery
6.1 Introduction
6.2 Indications, contraindications, and prerequisites for operative vaginal delivery
6.3 Classification system for operative vaginal delivery
6.4 Technical aspects of operative vaginal delivery
6.5 Effectiveness of operative vaginal delivery
6.6 Maternal morbidity
6.7 Pelvic floor dysfunction after operative vaginal delivery
6.8 Neonatal morbidity
6.9 Long-term neonatal outcomes
6.10 Mode of delivery: sequential instruments versus cesarean section
6.11 Subsequent pregnancy outcomes following operative vaginal delivery
6.12 The future of operative vaginal delivery
6.13 Conclusion
References
CHAPTER 7: Cesarean delivery
7.1 Introduction
7.2 Cesarean technique
7.3 Postcesarean delivery care
7.4 Considerations for cesarean under special scenarios
References
CHAPTER 8: Trial of labor after cesarean
8.1 Background
8.2 Risks of trial of labor after cesarean
8.3 Predictors of vaginal birth after cesarean
8.4 Uterine rupture
8.5 Pregnancy management
References
CHAPTER 9: Malpresentation and malposition
9.1 Introduction
9.2 Malpresentation
9.3 Malposition
9.4 Conclusions
References
CHAPTER 10: Multiple gestations
10.1 Introduction
10.2 Perinatal and maternal complications
10.3 Intrapartum preparation
10.4 Timing of delivery
10.5 Delivery
10.6 Vertex/vertex
10.7 Vertex/nonvertex
10.8 Nonvertex first twin
10.9 Cesarean delivery
10.10 Special cases
10.11 Special procedures
10.12 Conclusion
References
CHAPTER 11: Obstetrical emergencies
11.1 Background
11.2 Postpartum hemorrhage
11.3 Shoulder dystocia
11.4 Umbilical cord prolapse
11.5 Head entrapment
11.6 Seizure
11.7 Cardiopulmonary arrest and perimortem cesarean delivery
11.8 Summary
References
CHAPTER 12: Surgical management of obstetrical emergencies
12.1 Introduction
12.2 Uterine tamponade and packing
12.3 Uterine compression sutures
12.4 Uterine compression suture technique
12.5 Uterine artery ligation
12.6 Combination procedures for uterine preservation
12.7 Hypogastric artery ligation
12.8 Peripartum hysterectomy
12.9 Retained placenta
12.10 Obstetric laceration
12.11 Acute postpartum hematoma
12.12 Emergency cesarean
12.13 Perimortem cesarean
12.14 Conclusion
References
CHAPTER 13: Maternal disorders affecting labor and delivery
13.1 Hypertensive disorders of pregnancy
13.2 Gestational hypertension
13.3 Chronic hypertension/superimposed preeclampsia
13.4 Preeclampsia
13.5 Management of preeclampsia in labor
13.6 Eclampsia
13.7 Cardiac disease
13.8 Pulmonary disease
13.9 Renal disease
13.10 Diabetes
13.11 Neurologic disorders
13.12 Infections
References
CHAPTER 14: Fetal disorders affecting labor and delivery
14.1 Growth disturbances
14.2 Hemophilia
14.3 Skeletal dysplasias
14.4 Genetic abnormalities
14.5 Cardiac defects
14.6 Abdominal wall defects
14.7 Myelomeningocele
References
CHAPTER 15: Labor and delivery management of the obese gravida
15.1 Intrapartum management
15.2 Cesarean section
References
CHAPTER 16: Intrapartum and postpartum infections
16.1 Introduction
16.2 Group B
Streptoccocus
16.3 Varicella
16.4 Urinary tract infections / pyelonephritis
16.5 Parvovirus
16.6 Listeriosis
16.7 Human immunodeficiency virus / acquired immunodeficiency syndrome
16.8 Chorioamnionitis
16.9 Rubella
16.10 Toxoplasmosis
16.11 Hepatitis B
16.12 Hepatitis C
16.13 Cytomegalovirus
16.14 Herpes
16.15 Wound infections
16.16 Endometritis
16.17 Septic pelvic thrombophlebitis
16.18 Mastitis
References
CHAPTER 17: Obstetric anesthesia
17.1 A brief history of obstetric anesthesia
17.2 Anesthetic implications of the physiology of labor and delivery
17.3 Pain sensation in pregnancy, labor, and delivery
17.4 Management of pain in labor and delivery
17.5 Neuraxial techniques
17.6 Surgical anesthesia for the parturient
17.7 Non-delivery surgical anesthesia for the parturient
17.8 Hypertensive diseases of pregnancy
17.9 Management of obstetric hemorrhage
17.10 Anesthetic implications of specific maternal co-morbidities
References
CHAPTER 18: Postpartum care
18.1 Goals of care
18.2 Postpartum physiologic changes
18.3 The fourth stage of labor
18.4 Complications
Acknowledgments
References
CHAPTER 19: Development of an obstetrical patient safety program
19.1 Introduction
19.2 Background and fundamentals of patient safety
19.3 Building blocks of an obstetric patient safety program
19.4 Measuring patient safety
19.5 The evidence on quality improvement in obstetrics
19.6 Conclusion
References
Index
End User License Agreement
Chapter 01
Table 1.1 Goals of antenatal childbirth classes.
Table 1.2 Potential effects of childbirth classes identified in research.
Table 1.3 Prevalent models of antepartum education.
Table 1.4 Common methods of non-pharmacologic and pharmacologic pain control for labor and delivery.
Table 1.5 Possible benefits of group prenatal care.
Chapter 02
Table 2.1 Comparison of study populations between Friedman's study and the current study.
Table 2.2 Characteristics of the parturients by parity (weighted), Consortium on Safe Labor, 2002–2008.
Table 2.3 Duration of labor in hours by parity in spontaneous onset of labor.
Table 2.4 Comparison between CPP and CSL in nulliparous women.
Table 2.5 Duration of labor (in hours) in nulliparas based on cervical dilation at admission, National Collaborative Perinatal Project (CPP), 1959–1966.
Table 2.6 Maternal and labor characteristics of nulliparous women stratified by length of the first stage of labor.
*
Table 2.7 Adjusted odds ratios of perinatal outcomes in multivariate logistic regression analyses stratified by length of the first stage of labor.
Chapter 04
Table 4.1 Bishop scoring system.
Table 4.2 Examples of oxytocin regimens.
Table 4.3 Example of midtrimester oxytocin regimen.
Table 4.4 Examples of prostaglandin regimens for cervical ripening at term.
Chapter 05
Table 5.1 Standard nomenclature – the EFM category system.
Chapter 06
Table 6.1 ACOG classification of types of forceps delivery.
Table 6.2 Forceps delivery versus vacuum delivery: risk of maternal perineal trauma.
Table 6.3 Forceps delivery versus vacuum delivery: neonatal trauma.
Table 6.4 Rate of intracranial hemorrhage by mode of delivery.
Table 6.5 Maternal outcomes and preferences regarding subsequent pregnancy following delivery during the second stage of labor by operative vaginal delivery compared to cesarean delivery.
Chapter 08
Table 8.1 Maternal risks by route of delivery in women with a prior cesarean.
Table 8.2 Neonatal risks by route of delivery in women with a prior cesarean.
Chapter 09
Table 9.1 Proportion of singleton live births that were delivered in breech presentation in the US in 2008, with stratification by gestational age.
Table 9.2 Factors associated with success/failure of external cephalic version.
Chapter 10
Table 10.1 Maternal-fetal risks of multiple gestations.
Table 10.2 Intrapartum preparation in multiple gestations.
Table 10.3 Nonvertex second twin-similar outcomes for cesarean and vaginal delivery.
Table 10.4 Studies favoring cesarean for delivery of nonvertex second twin.
Table 10.5 Trial of labor after cesarean (TOLAC) in twins.
Chapter 11
Table 11.1 Etiology and risk factors for postpartum hemorrhage.
Table 11.2 Medical and surgical management of postpartum hemorrhage.
Table 11.3 Blood product components.
Table 11.4 “HELPERR” Mnemonic for management of shoulder dystocia.
Chapter 13
Table 13.1 Systolic and diastolic blood pressure criteria for diagnosis of mild and severe chronic hypertension.
Table 13.2 Recommended gestational age for delivery for women with chronic hypertensive disease in pregnancy.
Table 13.3 Diagnostic criteria for preeclampsia and preeclampsia with severe features.
Table 13.4 Maternal and fetal indications for delivery in patients with severe preeclampsia.
Table 13.5 The content, volume, and indications for blood product replacement in the case of severe hemorrhage or coagulopathy.
Table 13.6 Subsets of oliguria (I–III), the associated hemodynamic findings, and recommended treatments.
Table 13.7 Indications for invasive monitoring of maternal status in preeclampsia.
Table 13.8 New York Heart Association classification of heart failure by patient symptoms.
Table 13.9 Maternal cardiac disease and risk stratification during pregnancy.
Table 13.10 Indications for endocarditis prophylaxis in the pregnant patient during labor and delivery.
Table 13.11 Recommended antibiotic prophylaxis regimens for prevention of bacterial endocarditis for women during labor and delivery.
Table 13.12 White’s classification of diabetes.
Table 13.13 Carpenter–Coustan blood glucose cutoffs for the 100-gram glucose test in pregnancy. Two or more values elevated above the cutoffs are used to diagnose the patient with gestational diabetes.
Table 13.14 Duration and onset of action for various types of insulin used in pregnancy.
Table 13.15 Management of fluid and metabolic derangements associated with diabetic ketoacidosis in pregnancy.
Table 13.16 Clinical presentation and diagnostic work-up for various neurologic conditions commonly seen in pregnancy.
Table 13.17 Dosages of commonly used antiepileptic drugs in pregnancy.
Table 13.18 Recommended treatments for opportunistic infections in AIDs patients.
Table 13.19 Recommend doses of antiviral medications for herpes in pregnancy.
Chapter 14
Table 14.1 Various maternal, fetal, and placental factors leading to intrauterine growth restriction of the fetus.
Table 14.2 Features of osteogenesis imperfecta by type.
Table 14.3 Considerations and recommended mode of delivery for fetal congenital heart defects.
Chapter 16
Table 16.1 GBS indications for treatment.
Chapter 17
Table 17.1 Systemic opioids commonly used for labor pain relief.
Table 17.2 New York Heart Association functional capacity.
Table 17.3 Central hemodynamic assessment of normal term pregnancy.
Table 17.4 Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy.
Table 17.5 Prevention of bacterial endocarditis.
Table 17.6 Prevention of bacterial endocarditis.
Table 17.7 Anesthetic implications of systemic lupus erythematosus.
Table 17.8 Anesthetic implications of rheumatoid arthritis.
Table 17.9 Clinical classification of myasthenia gravis.
Chapter 18
Table 18.1 Trajectory of normal recovery in the inpatient period.
Table 18.2 Contraindications to breastfeeding.
Table 18.3 CDC categories for classifying hormonal contraceptives and intrauterine devices.
Table 18.4 Recommendations for postpartum hormonal, intrauterine, and barrier contraceptive use.
Table 18.5 Etiology and risk factors for postpartum hemorrhage.
Table 18.6 Key issues in hemorrhage management, by stage of hemorrhage.
Table 18.7 Uterotonics.
Table 18.8 Baseline risk of postpartum VTE of > 3%.
Table 18.9 VTE recommendations for antepartum and postpartum management: comparison.
Table 18.10 Differential diagnosis of postpartum hypertension.
Table 18.11 Differential diagnosis of postpartum headache.
Table 18.12 Risk factors for anal sphincter injury and perineal wound breakdown.
Table 18.13 Helpful and unhelpful responses for grieving parents.
Chapter 19
Table 19.1 Obstetric Adverse Outcome Index (AOI) indicators [44].
Chapter 01
Figure 1.1 The Pain Management Model.
Figure 1.2 Mastery as the key to childbirth satisfaction.
Chapter 02
Figure 2.1 Comparison between the Friedman curve and the pattern of cervical dilation based on the current data.
Figure 2.2 Patterns of cervical dilation (left) and fetal descent (right) in nulliparous women.
Figure 2.3 Average labor curves by parity in singleton term pregnancies with spontaneous onset of labor, vaginal delivery, and normal neonatal outcomes. P0, nulliparous women; P1, women of parity 1; P2, women of parity 2 or higher. The Consortium on Safe Labor, 2002–2008.
Figure 2.4 The average labor curves for nulliparas in the CPP and CSL cohorts. Average labor curves for women by study with singleton term pregnancies presenting in spontaneous labor with vaginal delivery for nulliparas. Curves were evaluated at the average values of the combined population for maternal age, maternal race, body mass index at delivery, spontaneous rupture of membranes, gestational age, and birthweight. Collaborative Perinatal Project (CPP) was conducted from 1959 to 1966; Consortium on Safe Labor (CSL) was conducted from 2002 to 2008.
Figure 2.5 The average labor curves for multiparas in the CPP and CSL cohorts. Average labor curves for women by study with singleton term pregnancies presenting in spontaneous labor with vaginal delivery for nulliparas. Curves were evaluated at the average values of the combined population for maternal age, maternal race, body mass index at delivery, spontaneous rupture of membranes, gestational age, and birthweight. Collaborative Perinatal Project (CPP) was conducted from 1959 to 1966; Consortium on Safe Labor (CSL) was conducted from 2002 to 2008.
Figure 2.6 The average labor curves by parity in women with singleton term pregnancies with spontaneous onset of labor and vertex presentation who completed the first stage of labor and whose newborns had 5-minute Apgar scores of at least 7. The National Collaborative Perinatal Project, 1959–966. P0, nulliparas; P1, parity 1; P2_, parity 2 or higher.
Chapter 04
Figure 4.1 Illustration of Dilapan
®
. (a) Dilapan prior to insertion; (b) Dilapan after fluid absorption and expansion.
Figure 4.2 Image of balloon catheters. Top: Foley catheter inflated with 30 mL sterile saline. Bottom: Cook
®
Balloon catheter with 60 mL inflated in the cervical balloon and 40 mL inflated in the vaginal balloon.
Figure 4.3 Example of guidelines for scheduling induction of labor.
Chapter 05
Figure 5.1 Fetal scalp electrode (FSE). (a) FSE in the plastic introducer; (b) FSE electrode to be applied to the fetal scalp.
Figure 5.2 Sample of bedside monitoring of EFM and contractions; uterine contractions are found in the lower band.
Figure 5.3 An intrauterine pressure catheter (IUPC) inside its plastic guide, ready for insertion.
Figure 5.4 A prolonged deceleration; note the fetal heart rate baseline in the 150s.
Figure 5.5 Repetitive variable decelerations.
Figure 5.6 Amnioinfusion: intrauterine pressure catheter connected with intravenous tubing to a saline infusion required to start an amnioinfusion.
Chapter 06
Figure 6.1a Simpson forceps demonstrating fenestrated blades and parallel shanks.
Figure 6.1b Simpson forceps with a Luikart modification defined by the addition of pseudo-fenestrated blades.
Figure 6.2 Kiwi® OmniCup vacuum extractor: Soft cup with handheld pump designed for single operator use.
Chapter 07
Figure 7.1 Vertical midline and transverse skin incision at cesarean delivery.
Figure 7.2 Low-transverse, low-vertical, and classical uterine incisions
.
Figure 7.3 Closure of low-transverse uterine after delivery of the fetus and placenta with continuous suture.
Chapter 10
Figure 10.1 Fetal death rate and prospective risk of fetal death (stillbirth) for singleton and twin gestations.
Figure 10.2 Three presentation alternatives encountered in twin gestations and their relative frequencies.
Figure 10.3 Interlocking chins of a breech/vertex twin gestation resulting in an impacted delivery.
Figure 10.4 Deflexion of the head of breech twin A due to the influence of the vertex of twin B.
Figure 10.5 During the delivery of twin A, an assistant uses the ultrasound transducer to identify the lie of twin B and initiates efforts to induce the fetal version to a cephalic presentation.
Figure 10.6 Following delivery of twin A, the operator uses both hands to perform a forward roll into a cephalic presentation.
Chapter 11
Figure 11.1 Sample form for documentation of shoulder dystocia events.
Figure 11.2 American Heart Association Maternal Cardiac Arrest algorithm.
Chapter 12
Figure 12.1 Bakri Balloon for uterine tamponade.
Figure 12.2 Glenveigh Belfort-Dildy Obstetric Tamponade System (ebb
TM
).
Figure 12.3 Drawing of the B-Lynch uterine compression suture.
Chapter 13
Figure 13.1 Recommendations from the American College of Obstetricians and Gynecologists for the use of intravenous labetalol and hydralazine in the management of severe range blood pressure.
Figure 13.2 Recommendations for anticoagulation prophylaxis or treatment during the antepartum and postpartum period for women with a history of VTE or inherited thrombophilia from the American College of Obstetricians and Gynecologists. Low-risk thrombophilias include factor V Leiden heterozygous, prothrombin mutation heterozygous, and protein C or S deficiency. High risk thrombophilias include antithrombin deficiency, double heterozygous prothrombin mutation and factor V Leiden, factor V Leiden homozygous, and prothrombin mutation heterozygous.
Figure 13.3 Prophylactic and therapeutic anticoagulation doses for the antepartum and postpartum periods from the American College of Obstetricians and Gynecologists.
Figure 13.4 Flowchart for management of status epilepticus in a pregnant patient.
Chapter 16
Figure 16.1 GBS treatment regimens.
Figure 16.2 Ascending pyelonephritis.
Figure 16.3 Parvo virus treatment flow diagram.
Figure 16.4 Chorioamnionitis.
Figure 16.5 Necrotizing fasciitis.
Figure 16.6 Mastitis.
Chapter 18
Figure 18.1 Anatomy of a proper latch.
Figure 18.2 The uterine fundus can be replaced by steady upward pressure from the provider’s upturned hand.
Figure 18.3 After replacement, the provider’s hand should remain in place while contractions are stimulated.
Figure 18.4 Management algorithm for persistent postpartum hypertension.
Figure 18.5 Evaluation of severe postpartum headache.
Figure 18.6 Sensitive photography assists families with creating mementos after perinatal loss.
Chapter 19
Figure 19.1 Example of a chain of command.
Figure 19.2 and Figure 19.3 Examples of a laminated reference card outlining the key principles of team training.
Figure 19.4 and Figure 19.5 Examples of a laminated reference card outlining the key principles of electronic fetal monitoring interpretation.
Figure 19.6 The Yale-New Haven Hospital obstetric Adverse Outcomes Index from September 2004 to August 2007.
Cover
Table of Contents
Begin Reading
iii
iv
vii
viii
ix
x
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
EDITED BY
George A. Macones MD
Mitchell and Elaine Yanow Professor and ChairDepartment of Obstetrics and GynecologyWashington University School of MedicineSt Louis, MO, USA
SECOND EDITION
This edition first published 2016 © 2016, 1997 by John Wiley & Sons, Ltd
Registered OfficeJohn Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Offices9600 Garsington Road, Oxford, OX4 2DQ, UKThe Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK111 River Street, Hoboken, NJ 07030-5774, USA
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
Lesen Sie weiter in der vollständigen Ausgabe!
